MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval
Company Advances IP Portfolio With New Patent Applications Covering Novel Molecule Families
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
MYCO-001 Smoking Cessation Clinical Trial Moves Forward Following Conditional IRB Approval
Company Advances IP Portfolio With New Patent Applications Covering Novel Molecule Families
Read more at globenewswire.com